 The purpose of this study is to determine the short-term effects of the antimalarial medication, hydroxychloroquine HCQ, compared with placebo using frequently sampled intravenous glucose tolerance testing FSIGTT methodology to study changes in insulin secretion and glucose tolerance in subjects at risk for developing Type 2 diabetes. 